A nonprofit website dedicated to providing the most reliable and complete information available.
Breastcancer.org
Provides educational materials, events, newsletters, a Young Survivors Network, and a toll-free helpline at 800-753-5222.
Living Beyond Breast Cancer
A comprehensive site that offers a toll-free helpline (1-800-I'M AWARE), educational materials, advocacy, and fundraising events.
Susan G. Komen for the Cure

Adding Avastin May Slow Disease Progression
Studies have shown that Avastin, an angiogenesis inhibitor, has delayed disease progression in breast cancer patients, but a survival benefit has yet to be seen.
Herceptin Combinations Improve Survival, Lessen Heart Toxicity
Two recent studies offer hope of enhancing both the effectiveness and safety of Herceptin, the drug that helped introduce the era of targeted therapy.
Screening Options Challenging for High-Risk Women
Studies have suggested that MRI, along with mammography, is the best means of detecting breast cancer earlier among high-risk women.
|
|
Triple-NegativeThere's now something to take aim at in triple-negative breast cancer. |
|
|
TreatmentAs data emerge from a surge of new therapies, doctors combine the best of the best. |
|
|
Non-invasive CancerIn Situ Breast Cancer: Is It Really Cancer? Status of noninvasive breast cancer gets some clarity. |
|
|
Metastatic CancerThree women share the uncertainty of living with metastatic breast cancer. |
|
|
Breast ReconstructionWhy aren't more women having breast reconstruction? |
|
|
ER-PositiveDoes CYP2D6 Predict Who Benefits From Tamoxifen? An enzyme called CYP2D6 converts tamoxifen to its active form, and some research has suggested that if the enzyme is blocked, tamoxifen won’t be as effective, thus causing patients to recur sooner than women with normal enzyme activity. |